Ali, Al Hasim S.

HRN: 25-35-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2024
CEFUROXIME 750MG (VIAL)
06/28/2024
07/04/2024
IV
250mg
Q8h
PCAP C
Waiting Final Action 
07/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/01/2024
07/07/2024
IVTT
350mg
Q6h
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: